Charlie Cook, Director MSLs at Takeda, discusses metrics and how the game has changed since Covid 19
Charlie shares….
👉 His views on Quality vs Quantity
👉 The importance of focusing on strategic goals
👉 Advice for the future of Medical Affairs
👉 Why MSLs need to communicate VALUE
The podcast is available through the links below:
️ Spotify: https://lnkd.in/dRrSEyn
️ Apple: https://lnkd.in/egSthAz
️ Stitcher: https://lnkd.in/eqB-2wb
Now on YouTube Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA
Now on Instagram Please subscribe:
https://www.instagram.com/msl_talk_podcast/
(0:00) Introduction and guest overview
(1:01) Charlie Cook's background and role at Takeda
(2:02) Evolution of MSL metrics: Pre, During, and Post-COVID
(4:21) Origin and implementation of metrics in medical affairs
(6:26) Aligning metrics with strategic objectives across drug lifecycles
(8:35) Territory-specific considerations for MSL metrics
(10:40) Challenges in MSL metric tracking and stress management
(13:10) Impact of metrics on MSL behavior and future interaction models
(18:28) Flexibility and challenges in MSL and KOL interactions
(20:51) Organizational strategies for MSLs in a hybrid environment
(22:14) Role of MSL managers in value communication and performance evaluation
(25:02) Skills development for future MSLs
(27:10) Enhancing virtual meeting efficiency and effectiveness
(28:35) Importance of listening skills and emotional intelligence in MSL roles
(30:39) Balancing and documenting MSL metrics and qualitative achievements
(32:20) Closing remarks and final thoughts